James V. Mazzo


James V. Mazzo

Director


James V. (Jim) Mazzo is Executive Chair of Neurotech, a private clinical stage biotech company focused on developing transformative therapies for chronic retinal diseases.

Mazzo is an Advisor for Anivive, Bain, CVC Private Equity, and Zeiss. He sits on the Boards of Emmecell, Iantrek, Visus, Pulse Medica, Signal 12, Remonihealth, Patient Square Capital, Neurotrigger, and is the Executive Chair of Centricity Vision. He serves as President of the Ophthalmology Foundation and Board Chair of the Gavin Hebert Eye Institute.

Mazzo is on the Advisory Boards of the AAO Foundation, the AGS Foundation, NASA’s Mission to Mars Committee, is an Officer in the Order of St. John, and a Board Member of the Anaheim Ducks Foundation. Mazzo is one of the ophthalmic industry’s best known and most respected business leaders with more than 40 years of proven experience. His global reputation for building and running world-class organizations is based on twenty-two years of leading Allergan’s North American and European eye care organizations;

Chairman, President and CEO of Advanced Medical Optics (AMO); EVP of Abbott’s global ophthalmology business; Executive Chair and CEO of AcuFocus; Global President of Ophthalmic Devices for Carl Zeiss Meditec; and President, CEO and Member of the Board for Avellino. Additionally, he is the Founder and Past Chair of Octane, a member of the International Intraocular Implant Club (lllC) and Executive Committee Board Member with the Medical Device Manufacturers Association (MDMA).

His accomplishments and contributions to the healthcare industry, business and educational communities include serving as Board Chair for AdvaMed, member of the University of California at Irvine Foundation, Vice Chair Trustee with Chapman University, Richard Nixon Foundation Board Member, and years of dedicated experience in the medical device industry including cardiology, dermatology, orthopedics, and ophthalmology. Mazzo’s accolades include recognition as a multi-time Top 100 Innovator in Ophthalmology, and one of Orange County’s Top 50 Executives.

In 2023 he received the Ellis Island Medal of Honor, the Lindstrom Leadership Award, and the Orange County Eye Project Lifetime Achievement Award.